CALGARY, Alberta, Jan. 17, 2025 (GLOBE NEWSWIRE) -- ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), ...

FOR centuries, gout has been a deeply misunderstood disease, associated only with jolly, indulgent, and often big men. When Henry VIII was diagnosed, it became firmly entrenched in popular belief ...

Medically reviewed by Scott J. Zashin, MD Pain in the joint of your big toe is a fairly common issue that generally requires ...

In a significant milestone for Ayurvedic medicine, Amrith Noni has successfully completed human clinical trials for its flagship product, Amrith Noni Artho Plus. Conducted in collaboration with ...

The NHS has listed what it believes to be the 20 top most painful conditions a person can suffer from. While there are ...

A recent study highlights a surprising issue for people living with gout in the United States: most gout flares are never ...

Diseases of the joints are known as arthritis. The term is derived from the Greek word that means exactly that: diseases of ...

New treatments like dotinurad provide safer, more effective solutions for millions battling gout and hyperuricemia.

The global intravenous pegloticase market is poised for substantial growth, projected to reach USD 11.61 Billion by 2033 from ...

With the clinical development of XORLO TM1 having advanced sufficiently, including completion of a pivotal program, XORTX is initiating discussions for the XRx-026 program with the US Food and Drug ...

XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. The company is actively involved in creating ...